MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 238 filers reported holding MYRIAD GENETICS INC in Q1 2017. The put-call ratio across all filers is 2.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $4,219,000 | -19.2% | 253,090 | -0.2% | 0.01% | -16.7% |
Q3 2016 | $5,221,000 | -32.9% | 253,678 | -0.2% | 0.01% | -40.0% |
Q2 2016 | $7,776,000 | -13.3% | 254,106 | +6.1% | 0.01% | -16.7% |
Q1 2016 | $8,965,000 | -10.6% | 239,515 | +3.0% | 0.01% | -7.7% |
Q4 2015 | $10,032,000 | +15.8% | 232,434 | +0.6% | 0.01% | +8.3% |
Q3 2015 | $8,661,000 | +8.9% | 231,080 | -1.2% | 0.01% | +20.0% |
Q2 2015 | $7,953,000 | +794.6% | 233,970 | +831.6% | 0.01% | +900.0% |
Q1 2015 | $889,000 | -1.0% | 25,116 | -4.8% | 0.00% | 0.0% |
Q4 2014 | $898,000 | -13.8% | 26,369 | -2.4% | 0.00% | 0.0% |
Q3 2014 | $1,042,000 | -48.2% | 27,006 | -47.8% | 0.00% | -66.7% |
Q2 2014 | $2,013,000 | -71.0% | 51,709 | -74.5% | 0.00% | -70.0% |
Q1 2014 | $6,946,000 | +70.2% | 203,149 | +4.4% | 0.01% | +66.7% |
Q4 2013 | $4,082,000 | +186.1% | 194,575 | +220.3% | 0.01% | +200.0% |
Q3 2013 | $1,427,000 | -0.1% | 60,741 | +14.3% | 0.00% | -33.3% |
Q2 2013 | $1,428,000 | – | 53,134 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 6,635,000 | $106,425 | 3.51% |
Glenview Capital Management | 3,783,982 | $60,695,071 | 1.37% |
AMH Equity Ltd | 47,285 | $758,451 | 0.83% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,973,312 | $31,651,924 | 0.75% |
EARNEST PARTNERS LLC | 3,473,281 | $55,711,427 | 0.32% |
AIMZ Investment Advisors, LLC | 40,985 | $657,399 | 0.29% |
PEREGRINE CAPITAL MANAGEMENT LLC | 280,767 | $4,503,503 | 0.13% |
Beverly Hills Private Wealth, LLC | 19,687 | $315,779 | 0.09% |
Artisan Partners Limited Partnership | 2,537,147 | $40,695,838 | 0.07% |
Jump Financial, LLC | 84,924 | $1,362,181 | 0.05% |